Last reviewed · How we verify

NCT00281307

Treatment of Rhinitis With Intranasal Vitamin E

Terminated NA Last updated 18 July 2017
What this trial tests

NA trial testing RRR-alpha-tocopherol 1,000 IU/mL in Rhinitis in 10 participants. Terminated before completion.

Timeline
7 December 2005
Primary endpoint
1 September 2007
1 September 2007

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment10
Start date7 December 2005
Primary completion1 September 2007
Estimated completion1 September 2007
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

18 and older, any sex, with Rhinitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many beneficial effects of vitamin E have been described, but vitamin E supplementation by mouth has not been effective in the treatment of nasal symptoms and allergic rhinitis. The investigators will evaluate the effect of vitamin E directly applied to the lining of the nose in individuals with moderate to severe rhinitis by symptom questionnaires.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rhinitis

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00281307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing